Home » Stocks » CHGCY

Chugai Pharmaceutical Co., Ltd. (CHGCY)

Stock Price: $22.43 USD -0.92 (-3.94%)
Updated Feb 26, 2021 3:59 PM EST - Market closed
Market Cap 73.54B
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 559.69M
EPS (ttm) 2.85
PE Ratio 7.88
Forward PE 31.65
Dividend $0.58
Dividend Yield 2.59%
Trading Day February 26
Last Price $22.43
Previous Close $23.35
Change ($) -0.92
Change (%) -3.94%
Day's Open 23.07
Day's Range 22.28 - 23.07
Day's Volume 45,518
52-Week Range 15.3333 - 29.32

News

There are no news available yet.

About CHGCY

Chugai Pharmaceutical Company, together with its subsidiaries, engages in the research, development, manufacture, marketing, and distribution of prescription medicines in Japan and internationally. The company's products for oncology primarily include Avastin, Herceptin, Rituxan, Alecensa, Perjeta, Xeloda, Tarceva, Kadcyla, Zelboraf, Neutrogin, Tecentriq, and Gazyva; bone and joint diseases/autoimmune diseases comprise Actemra, Edirol, Suvenyl, and Bonviva; renal diseases consist of Mircera and Oxarol; and other diseases comprise Tamiflu, CellC... [Read more...]

Industry
Drug Manufacturers-General
Founded
1925
CEO
Tatsuro Kosaka
Employees
7,555
Stock Exchange
OTCMKTS
Ticker Symbol
CHGCY
Full Company Profile